Market Overview

UPDATE: Roth Raises Target On Applied Genetics Technologies, Says 'Despite the market not fully appreciating the data given how the stock traded, we continue to believe that the results suggest that AGTC could have a best-in-class therapy'


This headline-only article is meant to show you why a stock is moving, the most difficult aspect of stock trading. Every day we publish hundreds of headlines on any catalyst that could move the stocks you care about on Benzinga Pro, our flagship platform for fast, actionable information that promotes faster, smarter trading.

Benzinga Pro has an intuitively designed workspace that delivers powerful market insight, and is the solution of choice for thousands of professional and retail traders across the world.

Stop Googling for information and check out Benzinga Pro. You will never again be left in the dark on when a stock moves. You’ll have what you need to act in real-time — before the crowd.

Start your FREE 14-day trial of Benzinga Pro today.

Latest Ratings for AGTC

Nov 2020Roth CapitalMaintainsBuy
Nov 2020BerenbergInitiates Coverage OnBuy
Jun 2020Cantor FitzgeraldInitiates Coverage OnOverweight

View More Analyst Ratings for AGTC
View the Latest Analyst Ratings


Related Articles (AGTC)

Posted-In: Analyst Color News Price Target Analyst Ratings

Latest Ratings

BYNDCanaccord GenuityMaintains170.0
TSQBarrington ResearchUpgrades15.0
LBRTEvercore ISI GroupUpgrades15.0
NEXEvercore ISI GroupUpgrades6.0
RYTMCanaccord GenuityMaintains45.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at